Neuland Laboratories Share Price
22685.00-155.00 (-0.68%)
+46.67% past 1 Year
Corporate filings & documents
Announcements
Intimation about Schedule of Analyst / Institutional Investor Meeting on September 23 - 25 2026
4 days agoIntimation about Schedule of Analyst / Institutional Investor Meeting on September 23 - 25 2026
4 days agoPress Release
6 days agoPress Release
6 days agoIntimation about Schedule of Analyst / Institutional Investor Meeting on September 15 2026 and September 17 2026
1 week agoIntimation about Schedule of Analyst / Institutional Investor Meeting on September 15 2026 and September 17 2026
1 week agoDisclosure under Regulation 30 of SEBI Listing Regulations
1 week agoDisclosure under Regulation 30 of SEBI Listing Regulations
1 week agoAnnouncement under Regulation 30 (LODR) - Credit Rating
3 weeks agoAnnouncement under Regulation 30 (LODR) - Credit Rating
3 weeks agoCopy of Newspaper Publication
4 weeks agoCopy of Newspaper Publication
4 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Malabar India Fund Ltd
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Malabar India Fund Ltd
1 month agoIntimation regarding completion of US FDA Inspection
1 month agoIntimation regarding completion of US FDA Inspection
1 month agoTranscript of the Earnings Call conducted on August 5 2026
1 month agoTranscript of the Earnings Call conducted on August 5 2026
1 month agoIntimation about Schedule of Analyst / Institutional Investor Meeting on August 12 2026
1 month agoIntimation about Schedule of Analyst / Institutional Investor Meeting on August 12 2026
1 month agoCopy of Newspaper Publication
1 month agoCopy of Newspaper Publication
1 month agoAudio Recording of the Earnings call conducted on August 5 2026
1 month agoAudio Recording of the Earnings call conducted on August 5 2026
1 month agoDisclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacity
1 month agoDisclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacity
1 month agoDisclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guarantee
1 month agoDisclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guarantee
1 month agoInvestor Presentation on the Financial Results of the Company for the quarter ended June 30 2026
1 month agoInvestor Presentation on the Financial Results of the Company for the quarter ended June 30 2026
1 month agoPress Release on the Financial Results of the Company for the quarter ended June 30 2026
1 month agoPress Release on the Financial Results of the Company for the quarter ended June 30 2026
1 month agoUnaudited Financial Results of the Company for the quarter ended June 30 2026
1 month agoUnaudited Financial Results of the Company for the quarter ended June 30 2026
1 month agoUnaudited Financial Results of the Company for the quarter ended June 30 2026
1 month agoUnaudited Financial Results of the Company for the quarter ended June 30 2026
1 month agoVoting Results Scrutinizer Report and proceedings of 42nd Annual General Meeting held on August 4 2026
1 month agoVoting Results Scrutinizer Report and proceedings of 42nd Annual General Meeting held on August 4 2026
1 month agoVoting Results Scrutinizer Report and proceeding of 42nd Annual General Meeting held on August 4 2026
1 month agoVoting Results Scrutinizer Report and proceeding of 42nd Annual General Meeting held on August 4 2026
1 month agoIntimation under Regulation 30 of SEBI Listing Regulations
1 month agoIntimation under Regulation 30 of SEBI Listing Regulations
1 month agoQ1FY27 Earnings Call Intimation
1 month agoQ1FY27 Earnings Call Intimation
1 month agoNeuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2026
2 months agoNeuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2026
2 months agoIntimation of Loss of Share Certificate(s)
2 months agoIntimation of Loss of Share Certificate(s)
2 months agoAnnouncement under Regulation 30 (LODR) - Credit Rating
2 months agoAnnouncement under Regulation 30 (LODR) - Credit Rating
2 months agoConcalls & investor presentations
Aug 2026
May 2026
Feb 2026
Nov 2025
ConcallPresentation
Jul 2025
May 2025
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
Aug 2024
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
Aug 2023
May 2023
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
Aug 2022
May 2022
Feb 2022
Oct 2021
Aug 2021
May 2021
Feb 2021
Nov 2020